/Lists

Biotech Series B Investors & VC Firms

770 firms in this list, with a median first check of $500K. 199 of them lead rounds. Generated from verified public data and updated continuously.

Andreessen Horowitz
Menlo ParkSeed–Growth$500K – $50M
627 people
Antler
SingaporePre-Seed–Series C$125K
327 people
General Atlantic
New YorkSeries B–Late Stage$10M – $1B
534 people
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
111 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
222 people
Bessemer Venture Partners
San FranciscoSeed–Growth$50K – $100M
259 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$100K – $50M
157 people
Lightspeed Venture Partners
Menlo ParkSeed–Late Stage$1M – $5M
115 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
81 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
126 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
185 people
RA Capital
BostonSeed–Late Stage
278 people
Khosla Ventures
Menlo ParkPre-Seed–Growth$100K – $20M
49 people
Bain Capital
BostonPre-Seed–Late Stage
290 people
Kleiner Perkins
Menlo ParkPre-Seed–Growth$500K – $15M
37 people
Index Ventures
San FranciscoSeed–Growth$540K – $10.8M
66 people
Summit Partners
BostonSeries B–Growth$10M – $500M
131 people
F-Prime Capital
CambridgePre-Seed–Series C$3M – $10M
110 people
PMV
BrusselsPre-Seed–Growth
210 people
Felicis Ventures
San FranciscoPre-Seed–Growth$500K – $15M
48 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
227 people
Menlo Ventures
San FranciscoPre-Seed–Late Stage$1M – $20M
55 people
Andera Partners
ParisSeed–Growth
131 people
Qiming Venture Partners
BeijingSeed–Series B
64 people

Frequently asked questions

Who are the top biotech series b investors & vc firms?
Top biotech series b investors & vc firms include Andreessen Horowitz, Antler, General Atlantic, Alumni Ventures, General Catalyst, Bessemer Venture Partners, Sequoia Capital, Lightspeed Venture Partners — 770 firms in total meet the criteria.
What is the typical first check among biotech series b investors & vc firms?
The median first check among the 770 biotech series b investors & vc firms tracked here is $500K.
How many biotech series b investors & vc firms lead rounds?
199 of the 770 biotech series b investors & vc firms tracked here lead investment rounds.

Related lists

Data sourced from public filings and firms' own websites — see our methodology.

Biotech Series B Investors & VC Firms [2026] | Fundraising Fox